ElevateBio.

ElevateBio performed TCR runs comparing the IRO to an industry standard control at their site.

After just 3 hours of training, the ElevateBio team was able to successfully operate and execute the protocol on the IRO platform.

The IRO data generated by ElevateBio showed significantly higher cell yield and transduction efficiency (~46.3% IRO) compared to the control (~24.7%).

All other analytical results were comparable: viability, CD4/CD8 ratio and memory, activation and exhaustion panels.